V. Filipazzi

Cisplatin Plus Gemcitabine or Vinorelbine for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The MILES-2P Studies

Cesare Gridelli, Paolo Maione, Alfonso Illiano et al. · Journal of Clinical Oncology · 2007 · 79 citations · Full text

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials

Cesare Gridelli, Alessandro Morabito, Luigi Cavanna et al. · Journal of Clinical Oncology · 2018 · 67 citations · Full text

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Sara Pilotto, Antônio Rossi, Tiziana Vavalà et al. · Clinical Lung Cancer · 2017 · 45 citations

Medicine, Be-positive Study, Pathology +8

Transient blindness and seizure associated with cisplantin therapy

Marco Cattaneo, V. Filipazzi, E. Piazza et al. · Journal of Cancer Research and Clinical Oncology · 1988 · 41 citations · Full text

Transient Blindness, Blindsight, Ophthalmology +7

Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis

Daniele Fagnani, Riccardo Franchi, Camillo Porta et al. · Annals of Oncology · 2006 · 27 citations · Full text

Pulmonary Embolism, Thrombosis, Venous Disease +15